Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.46 Insider Own29.55% Shs Outstand23.67M Perf Week-11.73%
Market Cap9.45M Forward P/E- EPS next Y- Insider Trans-0.23% Shs Float19.24M Perf Month-5.98%
Income-10.34M PEG- EPS next Q- Inst Own7.13% Short Float1.37% Perf Quarter-24.78%
Sales0.47M P/S20.10 EPS this Y- Inst Trans-11.30% Short Ratio0.80 Perf Half Y-46.65%
Book/sh-0.08 P/B- EPS next Y- ROA-210.81% Short Interest0.26M Perf Year-78.90%
Cash/sh0.03 P/C9.94 EPS next 5Y- ROE-703.62% 52W Range0.30 - 2.92 Perf YTD-47.91%
Dividend Est.- P/FCF- EPS past 5Y30.13% ROI- 52W High-88.15% Beta1.42
Dividend TTM- Quick Ratio0.31 Sales past 5Y100.50% Gross Margin11.11% 52W Low15.18% ATR (14)0.03
Dividend Ex-Date- Current Ratio0.31 EPS Y/Y TTM28.66% Oper. Margin-2224.15% RSI (14)41.02 Volatility10.60% 5.94%
Employees20 Debt/Eq- Sales Y/Y TTM-65.49% Profit Margin-2208.76% Recom2.00 Target Price4.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q48.01% Payout- Rel Volume0.93 Prev Close0.33
Sales Surprise- EPS Surprise- Sales Q/Q-14.06% EarningsMay 14 AMC Avg Volume328.31K Price0.35
SMA20-9.39% SMA50-10.35% SMA200-31.87% Trades Volume306,819 Change5.68%
Date Action Analyst Rating Change Price Target Change
Apr-16-21Downgrade Dawson James Buy → Neutral
May-21-24 05:00PM
May-15-24 03:08AM
May-14-24 08:56PM
May-09-24 07:00AM
07:00AM Loading…
May-01-24 07:00AM
Apr-25-24 09:00AM
Apr-02-24 05:41PM
Apr-01-24 02:30PM
Mar-28-24 05:58AM
Mar-27-24 08:53PM
Mar-20-24 07:00AM
Mar-13-24 07:00AM
Mar-12-24 07:00AM
09:27AM Loading…
Mar-04-24 09:27AM
Feb-08-24 07:00AM
Jan-31-24 07:00AM
Jan-03-24 07:00AM
Dec-19-23 07:00AM
Dec-18-23 07:16AM
Nov-29-23 07:00AM
Nov-16-23 12:56PM
Nov-15-23 11:04AM
Nov-14-23 07:15AM
Nov-09-23 12:48PM
Nov-08-23 05:52PM
04:11PM Loading…
Nov-01-23 05:04PM
Oct-12-23 11:08AM
Oct-11-23 06:00AM
Sep-06-23 10:31AM
Sep-05-23 07:15AM
Aug-11-23 09:29AM
Aug-09-23 06:05PM
Aug-02-23 07:00AM
Jul-24-23 07:00AM
Jul-10-23 08:11AM
Jul-05-23 07:00AM
Jun-20-23 05:14PM
Jun-08-23 07:00AM
May-28-23 08:08AM
May-23-23 07:00AM
May-12-23 06:06AM
May-10-23 05:45PM
May-09-23 07:00AM
May-03-23 08:00PM
Apr-28-23 07:00AM
Apr-04-23 07:00AM
Apr-01-23 12:47PM
Mar-31-23 06:05AM
Mar-29-23 08:15AM
Mar-16-23 07:00AM
Mar-06-23 01:06PM
Feb-01-23 06:30AM
Jan-31-23 05:39AM
Dec-22-22 07:00AM
Dec-21-22 05:07AM
Dec-15-22 07:00AM
Dec-06-22 07:00AM
Nov-09-22 05:35PM
Nov-02-22 05:31PM
Oct-03-22 01:33PM
Sep-14-22 07:00AM
Sep-09-22 07:00AM
Sep-08-22 07:00AM
Sep-06-22 11:03AM
Aug-31-22 07:00AM
Aug-24-22 09:40AM
Aug-10-22 05:15PM
Aug-04-22 02:04PM
Aug-01-22 08:00AM
Jul-12-22 08:15AM
Jun-15-22 08:00AM
May-11-22 05:55PM
May-06-22 03:15PM
May-04-22 08:30AM
Apr-13-22 10:25AM
Apr-12-22 07:15AM
Mar-30-22 03:51PM
Mar-29-22 04:05PM
Mar-24-22 08:00AM
Mar-22-22 08:30AM
Mar-01-22 08:00AM
Feb-14-22 07:30AM
Feb-03-22 02:53PM
BioCardia, Inc. is a clinical-stage biotherapeutic company. It engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Altman PeterPresident and CEOApr 19 '24Buy0.372,7501,013558,697Apr 19 05:38 PM
Altman PeterPresident and CEOMar 28 '24Buy0.39500195555,947Mar 28 07:33 PM
Altman PeterPresident and CEOFeb 13 '24Buy0.46108,10850,000555,447Feb 15 07:00 AM
FROST PHILLIP MD ET AL10% OwnerJan 19 '24Sale0.43129,80255,8151,896,025Jan 22 08:38 PM
Altman PeterPresident and CEOMay 26 '23Buy1.606,2009,920469,239May 30 05:01 PM